| [1] |
Yamamoto K,Nakano M,Arita T,et al.Dissolution behavior and bioavailability of phenytoin from a ground mixture with microcry-stalline cellulose[J].J Pharm Sci,1976,65(10):1484-1488.
|
| [2] |
Mora M J,Tártara L I,Onnainty R,et al.Characterization,dissolution and in vivo evaluation of solid acetazolamide complexes[J].Carbohydr Polym,2013,98(1):380-390.
|
| [3] |
Aucamp M,Odendaal R,Liebenberg W,et al.Amorphous azithromycin with improved aqueous solubility and intestinal membrane permeability[J].Drug Dev Ind Pharm,2015,41(7):1100-1108.
|
| [4] |
Ambrogi V,Marmottini F,Pagano C.Amorphous carbamazepine stabilization by the mesoporous silicate SBA-15[J].Microporous Mesoporous Mater,2013,177(9):1-7.
|
| [5] |
Balfour JAB, Scott LJ. Cinacalcet hydrochloride[J]. Drugs,2005,65(2):271-281.
|
| [6] |
Braun DE,TöBbens DM,Kahlenberg V,et al.Structural and thermodynamic features of crystal polymorphs of R-cinacalcet hydrochloride[J].Cryst Growth Des,2008,8(11):4109-4119.
|
| [7] |
Hilden LR,Morris KR.Physics of amorphous solids[J].J Pharm Sci,2004,93(1):3-12.
|
| [8] |
Yu L.Amorphous pharmaceutical solids:preparation,characterization and stabilization[J].Adv Drug Deliv Rev,2001,48(1):27-42.
|
| [9] |
Graeser KA, Strachan CJ, Patterson JE, et al. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin[J].Cryst Growth Des,2008,8(1):128-135.
|
| [10] |
Lu Y,Du GH.Polymorphic Drugs(晶体药物)[M].Beijing:People′s Medical Publishing House,2009:109-110.
|
| [11] |
Ohta M,Buckton G.A study of the differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited different physical stabilities.[J].Int J Pharm,2005,289(1/2):31-38.
|
| [12] |
Zhao L,Zhao CC,Lu C,et al.Content determination of cinacalcet hydrochloride tablets by HPLC[J].China Pharm(中国药房),2014,25(13):1216-1217.
|
| [13] |
Karmwar P,Graeser K,Gordon KC,et al.Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods[J].Int J Pharm,2011,417(1):94-100.
|
| [14] |
Karmwar P,Graeser K,Gordon KC,et al.Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin[J].Eur J Pharm Biopharm,2012,80(2):459-464.
|
| [15] |
Savolainen M,Heinz A,Strachan C,et al.Screening for differences in the amorphous state of indomethacin using multivariate visualization[J].Eur J Pharm Biopharm,2007,30(2):113-123.
|
| [16] |
Sheth,AR,Bates,S,Muller,FX,et al.Local structure in amorphous phases of piroxicam from powder X-ray diffractometry[J].Cryst Growth De,2005,5(2):571-578.
|
| [17] |
Karmwar P,Graeser K,Gordon KC,et al.Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods[J].Int J Pharm,2011,417(1/2):94-100.
|
| [18] |
Patterson JE,James MB,Forster AH,et al.The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds[J].J Pharm Sci,2005,94(9):1998-2012.
|
| [19] |
Aaltonen J,Rades T.Commentary:towards physicorelevant dissolution testing:the importance of solid-state analysis in dissolution[J].Dissolut Technol,2009,16(2):47-54.
|
| [20] |
Alonzo DE,Zhang GG,Zhou D,et al.Understanding the behavior of amorphous pharmaceutical systems during dissolution[J].Pharm Res,2010,27(4):608-618.
|
| [21] |
Zhang F,Aaltonen J,Tian F,et al.Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin[J].Eur J Pharm Biopharm,2009,71(1):64-70.
|
下载:
